Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J Scheiermann, DM Klinman - Vaccine, 2014 - Elsevier
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …
被引用次数：350 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J Scheiermann, DM Klinman - Vaccine, 2014 - ncbi.nlm.nih.gov
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

J Scheiermann, DM Klinman - Vaccine, 2014 - europepmc.org
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J Scheiermann, DM Klinman - Vaccine, 2014 - infona.pl
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

[引用][C] Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J SCHEIERMANN, DM KLINMAN - Vaccine, 2014 - pascal-francis.inist.fr
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious
diseases and cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

J Scheiermann, DM Klinman - 2014 - cabidigitallibrary.org
Synthetic oligonucleotides (ODN) that express unmethylated" CpG motifs" trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

[引用][C] Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J Scheiermann, DM Klinman - Vaccine, 2014 - cir.nii.ac.jp
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious
diseases and cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J Scheiermann, DM Klinman - Vaccine, 2014 - pubmed.ncbi.nlm.nih.gov
Synthetic oligonucleotides (ODN) that express unmethylated" CpG motifs" trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.

J Scheiermann, DM Klinman - Vaccine, 2014 - europepmc.org
Synthetic oligonucleotides (ODN) that express unmethylated “CpG motifs” trigger cells that
express Toll-like receptor 9. In humans this includes plasmacytoid dendritic cells and B cells …

[引用][C] Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer

J SCHEIERMANN, DM KLINMAN - Vaccine, 2014 - Elsevier